Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2021 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms.
Soldevilla B, Lens-Pardo A, Espinosa-Olarte P, Carretero-Puche C, Molina-Pinelo S, Robles C, Benavent M, Gomez-Izquierdo L, Fierro-Fernández M, Morales-Burgo P, Jimenez-Fonseca P, Anton-Pascual B, Rodriguez-Gil Y, Teijo-Quintans A, La Salvia A, Rubio-Cuesta B, Riesco-Martínez MC, Garcia-Carbonero R. Soldevilla B, et al. Among authors: carretero puche c. Mol Oncol. 2023 Apr;17(4):582-597. doi: 10.1002/1878-0261.13393. Epub 2023 Mar 5. Mol Oncol. 2023. PMID: 36795001 Free PMC article.
Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data.
Fustero-Torre C, Jiménez-Santos MJ, García-Martín S, Carretero-Puche C, García-Jimeno L, Ivanchuk V, Di Domenico T, Gómez-López G, Al-Shahrour F. Fustero-Torre C, et al. Among authors: carretero puche c. Genome Med. 2021 Dec 16;13(1):187. doi: 10.1186/s13073-021-01001-x. Genome Med. 2021. PMID: 34911571 Free PMC article.
Metabolomic profile of neuroendocrine tumors identifies methionine, porphyrin, and tryptophan metabolisms as key dysregulated pathways associated with patient survival.
La Salvia A, Lens-Pardo A, López-López A, Carretero-Puche C, Capdevila J, Benavent M, Jiménez-Fonseca P, Castellano D, Alonso T, Teule A, Custodio A, Tafuto S, La Casta A, Spada F, Lopez-Gonzalvez A, Gil-Calderon B, Espinosa-Olarte P, Barbas C, Garcia-Carbonero R, Soldevilla B. La Salvia A, et al. Among authors: carretero puche c. Eur J Endocrinol. 2024 Jan 3;190(1):62-74. doi: 10.1093/ejendo/lvad160. Eur J Endocrinol. 2024. PMID: 38033321 Free article.
DREIMT: a drug repositioning database and prioritization tool for immunomodulation.
Troulé K, López-Fernández H, García-Martín S, Reboiro-Jato M, Carretero-Puche C, Martorell-Marugán J, Martín-Serrano G, Carmona-Sáez P, Glez-Peña D, Al-Shahrour F, Gómez-López G. Troulé K, et al. Among authors: carretero puche c. Bioinformatics. 2021 May 1;37(4):578-579. doi: 10.1093/bioinformatics/btaa727. Bioinformatics. 2021. PMID: 32818254 Free article.
vulcanSpot: a tool to prioritize therapeutic vulnerabilities in cancer.
Perales-Patón J, Di Domenico T, Fustero-Torre C, Piñeiro-Yáñez E, Carretero-Puche C, Tejero H, Valencia A, Gómez-López G, Al-Shahrour F. Perales-Patón J, et al. Among authors: carretero puche c. Bioinformatics. 2019 Nov 1;35(22):4846-4848. doi: 10.1093/bioinformatics/btz465. Bioinformatics. 2019. PMID: 31173067 Free PMC article.
Comprehensive Plasma Metabolomic Profile of Patients with Advanced Neuroendocrine Tumors (NETs). Diagnostic and Biological Relevance.
Soldevilla B, López-López A, Lens-Pardo A, Carretero-Puche C, Lopez-Gonzalvez A, La Salvia A, Gil-Calderon B, Riesco-Martinez MC, Espinosa-Olarte P, Sarmentero J, Rubio-Cuesta B, Rincón R, Barbas C, Garcia-Carbonero R. Soldevilla B, et al. Among authors: carretero puche c. Cancers (Basel). 2021 May 27;13(11):2634. doi: 10.3390/cancers13112634. Cancers (Basel). 2021. PMID: 34072010 Free PMC article.